🎤 Featured Speaker Spotlight | Jason J. McDougall 📍 Dalhousie University | Departments of Pharmacology & Anaesthesia We’re honoured to welcome Prof. Jason McDougall to our upcoming session on Medical Cannabis Research and Innovations. An internationally recognized expert in

Panel Spotlight | Beyond the Lab - Breakthroughs Transforming the Medical Cannabis Space We're excited to introduce the first panel session to kick-off Avicanna's 5th Medical Symposium, hosted by our very own Karolina Urban, PhD, MSc. Featuring: Carrie Cuttler 🌈 , Associate

Call for Abstracts Now Open! Are you driving innovation in medical cannabis research and innovation? Present your work to a community of scientists, clinicians, researchers, and industry partners at Avicanna's 5th Medical Symposium! We're inviting submissions on topics

📣 We're proud to share this in-depth feature from @TDRcapital on our strong performance and 51% YoY revenue growth! 🚀 Thank you for highlighting our continued momentum in the cannabinoid sector. 🌿 🎥 Watch the full video: youtu.be/eXHLgE23_T0 #Avicanna #ScienceFirst

Speaker Lineup Announcement | Session 2: Challenges Faced by Patients & Breaking Barriers for Access Why do patients still struggle to access medical cannabis? In session 2 of our 5th Medical Symposium, we’ll be bridging the gap and shine some light on barriers patients face and

🎤 Featured Speaker Spotlight | Dr. Daniel Bear Director, Humber Centre for Social Innovation, Humber College We’re thrilled to welcome Dr. Daniel Bear , Ph.D, to our speaker lineup for Session 2 of Avicanna’s 5th Annual Medical Symposium focused on Challenges Faced by Patients

🎤 Featured Speaker Spotlight | Carlo De Angelis , @uoft department of pharmacy Clinician Scientist - Oncology Pharmacy, Department of Pharmacy, Sunnybrook Health Sciences Centre Odette Cancer Centre University of Toronto We’re excited to welcome Dr. Carlo DeAngelis, PharmD, to our speaker lineup for

Speaker Lineup Announcement | Session 3: Pain & Harm Reduction - Exploring the intersection of cannabinoid-based medicine, chronic pain, and substance use We’re excited to present Session 3 of Avicanna’s 5th Medical Symposium, featuring two internationally recognized researchers

Exploring Cannabis & PTSD: What Does the Science Say? We’re excited to present the second installment of the MyMedi.ca Webinar Series! Join world-renowned neuroscientist Dr. Matthew Hill (Matt Hill) on Wednesday May 28th, 12–1 PM ET for:  Cannabis,

🗣️ Aras founded Avicanna with the vision of establishing an international biopharmaceutical company with a strict focus on medical and pharmaceutical applications of naturally derived medicines including cannabinoids. Avicanna (TSX:AVCN) 👉eu1.hubs.ly/H0k0YfG0

🎤 Featured Speaker Spotlight | Dr. Zachary Walsh, PhD, RPsych 📍BC Centre on Substance Use | University of British Columbia We are honoured to feature Dr. Zach Walsh, a leading clinical psychologist and researcher in the field of substance use and cannabinoid-based therapies at Avicanna’s 5th Medical

We're proud to announce and report the results of Q1 2025 and achieving our first profitable quarter! “Starting 2025 with positive momentum, we are proud to report our first profitable quarter—a milestone that reflects our strategic focus and operational discipline. With this

🎤 Featured Speaker Spotlight | Kelly Dunn, PhD, MBA Director, Kahlert Institute for Addiction Medicine Professor, UniveristyOfMichigan Session 3: Pain & Harm Reduction What happens when cannabinoids and opioids are combined? What factors influence how people respond? These are just some

We're excited to announce our sponsorship of a pilot Phase II Clinical Study on Osteoarthritis Pain - it's a multi-centre, blinded, randomized placebo-controlled investigator initiated study, to be led by Dr. Hance Clarke and conducted at University Health Network. The primary

🎤 Featured Speaker Spotlight | Dr. Evan Lewis 📍North Toronto Neurology What’s new — and what’s next — for cannabis-based therapies in #epilepsy? The answer is coming straight from one of the most respected minds in pediatric neurology and cannabinoid medicine: Dr. Evan Lewis.

🎤 Featured Speaker Spotlight | Dr. Dr. Martin Katzman , BSc, MD, FRCPC 📍 S.T.A.R.T Clinic for the Mood and Anxiety Disorders, Northern Ontario School of Medicine & Psychology, Lakehead University We’re honoured to welcome Dr Martin Katzman to our upcoming session on Bridging Science

Join Karolina Urban, PhD, MSc, executive Vice President, Medical Affairs at Avicanna, as she speaks with Dr. Evan Lewis, Pediatric Neurologist and Clinical Neural Physiologist, on the endocannabinoid system and the therapeutic potential in epilepsy. Dr. Urban sat down to